# Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

> **NCT04053439** · — · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 188 (estimated)

## Conditions studied

- Lymphoma
- Chemotherapeutic Toxicity

## Interventions

- **OTHER:** Blood test for determination of CHIP

## Key facts

- **NCT ID:** NCT04053439
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-08
- **Primary completion:** 2026-01
- **Final completion:** 2026-09
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2025-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053439, "Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT04053439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*